During the past decade, Hospital Sant Pau i Santa Tecla conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Sant Pau i Santa Tecla" #1 sponsor was "Spanish Lung Cancer Group" with 3 trials, followed by "Pfizer" with 2 trials sponsored, "Asociación para el Fomento de la Investigación y el Desarrollo Integral de la Oncología" with 1 trials sponsored, "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 1 trials sponsored and "ETOP IBCSG Partners Foundation" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Sant Pau i Santa Tecla" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Fundación ADEY" with 1 trials as a collaborator, "Spanish reumatology Society" with 1 trials as a collaborator and "TFS Trial Form Support" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Sant Pau i Santa Tecla" are "Breast Cancer" (2 trials), "Lung Cancer" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Breast Cancer, Male" (1 trials) and "COVID" (1 trials). Many other conditions were trialed in "Hospital Sant Pau i Santa Tecla" in a lesser frequency.

Most popular intervention types in "Hospital Sant Pau i Santa Tecla" are "Drug" (7 trials), "Other" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.9% Sodium chloride" (1 trials), "Aromatase inhibitor" (1 trials), "C19-IG 20%" (1 trials), "Capecitabine" (1 trials) and "IgG test" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Sant Pau i Santa Tecla" are 13 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Sant Pau i Santa Tecla". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Hospital Sant Pau i Santa Tecla, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Sant Pau i Santa Tecla, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".